46-60 of 178
Proteinuria in CKD Progression: Understanding Its Role and Monitoring Strategies
Clinician's RoundtableProteinuria in CKD Progression: Understanding Its Role and Monitoring Strategies
Gates B. Colbert, MD
Jared Hassler, MD
Innovations in IgAN Care: Addressing Challenges with Therapeutic Advances
Clinician's RoundtableInnovations in IgAN Care: Addressing Challenges with Therapeutic Advances
Charles Turck, PharmD, BCPS, BCCCP
Pietro A. Canetta, MD
Moving Beyond Immunosuppressive Therapy in IgAN
Clinician's RoundtableMoving Beyond Immunosuppressive Therapy in IgAN
Gates B. Colbert, MD
From Infusion Chair to Clinic Visit: How Subcutaneous Nivolumab May Simplify RCC Care
Project Oncology®From Infusion Chair to Clinic Visit: How Subcutaneous Nivolumab May Simplify RCC Care
Identifying C3G: Key Diagnostic Considerations and Challenges
On the Frontlines of C3GIdentifying C3G: Key Diagnostic Considerations and Challenges
Anuja Java, MD
Transforming C3G Care: New Advances in Targeted Treatment
On the Frontlines of C3GTransforming C3G Care: New Advances in Targeted Treatment
Anuja Java, MD
- advertisement
Biomarker Breakthroughs: A Look at What’s Next for Kidney Cancer Care
Project Oncology®Biomarker Breakthroughs: A Look at What’s Next for Kidney Cancer Care
Ryan Quigley
David F. McDermott, MD
Osteoporosis in CKD: Closing the Gaps in Diagnosis and Treatment
On the Frontlines of OsteoporosisOsteoporosis in CKD: Closing the Gaps in Diagnosis and Treatment
Ryan Quigley
Charles Ginsberg, MD
TILplus Score as a Potential Predictive Biomarker in First-Line ICI Therapy for mccRCC
Project Oncology®TILplus Score as a Potential Predictive Biomarker in First-Line ICI Therapy for mccRCC
Optimizing C3G Management: The Power of Lifestyle Changes and Supportive Care
On the Frontlines of C3GOptimizing C3G Management: The Power of Lifestyle Changes and Supportive Care
Richard Lafayette, MD, FACP
Patient Counseling in C3GN: From Disease Education to Shared Decision-Making
On the Frontlines of C3GPatient Counseling in C3GN: From Disease Education to Shared Decision-Making
Gates B. Colbert, MD
Challenges in C3GN Care: Managing Relapsing and Treatment-Resistant Disease
On the Frontlines of C3GChallenges in C3GN Care: Managing Relapsing and Treatment-Resistant Disease
Gates B. Colbert, MD
- advertisement
Advancing C3G Care with the Approval of a Complement Factor B Inhibitor
On the Frontlines of C3GAdvancing C3G Care with the Approval of a Complement Factor B Inhibitor
Enhancing Lupus Nephritis Outcomes: The Potential Impact of Lower Glucocorticoid Doses
Living RheumEnhancing Lupus Nephritis Outcomes: The Potential Impact of Lower Glucocorticoid Doses
APOL1 and Chronic Kidney Disease: New Findings in African Populations
Clinician's RoundtableAPOL1 and Chronic Kidney Disease: New Findings in African Populations
Rasheed A. Gbadegesin, MD, MBBS
